The Pharmaceutical and Biotechnology continue to dominate the world’s R&D expenditure, with more companies in the top 10 than any other sector. This year, whilst Novartis has knocked Roche from their top spot, individual R&D spends by pharma and biotechs fail to compete with the likes of Volkswagen and Samsung who’s spends were around $11 billion in 2013. Between the top 50 BigPharma and biotech companies $85.7 billion was spend on R&D in 2013, which represents a decrease in spending of $2.8 billion compared to 2012.
The Top 50 Pharmaceutical Companies by Research and Development Investment:
Pharma Rank
World Rank
Company
Country
$million
1
5
NOVARTIS
Switzerland
7173.5
2
6
ROCHE
Switzerland
7076.2
3
8
JOHNSON & JOHNSON
US
5933.6
4
12
MERCK US
US
5165.0
5
14
SANOFI-AVENTIS
France
4757.0
6
15
PFIZER
US
4750.2
7
21
GLAXOSMITHKLINE
UK
4154.3
8
23
ELI LILLY
US
4010.8
9
34
BAYER
Germany
3259.0
10
37
ASTRAZENECA
UK
3202.8
11
38
AMGEN
US
2960.6
12
39
BOEHRINGER INGELHEIM
Germany
2743.0
13
40
BRISTOL-MYERS SQUIBB
US
2705.4
14
45
TAKEDA PHARMACEUTICAL
Japan
2352.0
15
52
ABBVIE
US
2059.3
16
63
OTSUKA
Japan
1714.7
17
65
CELGENE
US
1603.4
18
66
NOVO NORDISK
Denmark
1567.4
19
68
GILEAD SCIENCES
US
1537.1
20
70
MERCK DE
Germany
1504.3
21
77
ASTELLAS PHARMA
Japan
1318.4
22
78
DAIICHI SANKYO
Japan
1316.6
23
95
ABBOTT LABORATORIES
US
1052.9
24
96
BIOGEN IDEC
US
1047.1
25
100
TEVA PHARMACEUTICAL INDUSTRIES
Israel
1031.1
26
124
EISAI
Japan
898.9
27
125
SERVIER
France
895.0
28
144
UCB
Belgium
781.0
29
150
ALLERGAN
US
754.7
30
165
SHIRE
UK
645.5
31
193
VERTEX PHARMACEUTICALS
US
508.3
32
215
ACTAVIS
Ireland
447.3
33
263
SHIONOGI
Japan
357.6
34
273
CSL
Australia
338.2
35
278
ONO PHARMACEUTICAL
Japan
334.5
36
282
MYLAN
US
330.8
37
284
ACTELION
Switzerland
329.6
38
296
HOSPIRA
US
305.2
39
307
ZOETIS
US
289.3
40
338
IPSEN
France
267.6
41
347
BIOMARIN PHARMACEUTICAL
US
257.3
42
356
FOREST LABORATORIES
US
251.4
43
357
GRUNENTHAL
Germany
250.9
44
365
BIOMERIEUX
France
235.7
45
380
ALEXION PHARMACEUTICALS
US
222.6
46
389
UNITED THERAPEUTICS
US
217.1
47
400
H LUNDBECK
Denmark
210.1
48
413
ILLUMINA
US
200.7
49
417
CHIESI FARMACEUTICI
Italy
198.0
50
446
NOVOZYMES
Denmark
185.1
Source: European Commission, The 2014 EU Industrial R&D Investment Scoreboard
The post Top 50 Pharmaceutical Companies 2014 appeared first on Total Biopharma.